US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the ...

BioCity Biopharma has reported positive Phase II results for SC0062 in treating IgA nephropathy, showing up to a 48.3% ...

US biotech major Gilead Sciences was trading nearly 2% higher in pre-market on Thursday after announcing its third-quarter ...

Maryland-based MacroGenics, a biopharma focused on discovering, developing, manufacturing and commercializing innovative ...

Oncology-focused biotech company Tango Therapeutics announced an update on its PRMT5 program. Tango noted that, based on ...

Arcus Biosciences and Gilead Sciences have reported promising Phase III results from their ARC-10 study of domvanalimab and ...

US drugmaker Sarepta Therapeutic saw its shares gain 2.4% to $127.97 as it reported financial results for the third quarter ...

Moderna posted Q3 2024 revenues of $1.9 billion, up from $1.8 billion in Q3 2023, with net income reaching $13 million, a turnaround from last year’s $3.6 billion loss. Growth was driven by strong US ...

Around half of the pharmaceutical products launched in the USA in 2023 underperformed, and 39% overperformed, according to ...

USA-based Acadia Pharmaceuticals has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease ...

PrognomiQ has raised $34 million in a series D round led by Seer, boosting its total funding to over $135 million. The funds ...

The congress is a collaboration of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy ...